Publicly Traded Cannabis Stock News
Access to capital is critical for any industry. The state-legal cannabis industry struggles in this area for several reasons, including federal illegality, stigma issues that reduce the investor base,...
Earlier this week, Canadian licensed cannabis producer OrganiGram (TSXV: OGI) (OTC: OGRMF), based in New Brunswick, announced a first-of-its-kind deal, with the provincial government giving the company up to $990,000...
Aurora Cannabis Provides Operational Update Company Surpasses 1,000 Registered Patients in Three Months VANCOUVER, BRITISH COLUMBIA–(Marketwired – April 1, 2016) – Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(OTCQB:ACBFF) (WKN:A1C4WM) (“Aurora” or the...
Alan Brochstein, CFA, presented “3 Years Later, Only a Few Cannabis Stocks Appear Capable to Deliver” at the MoneyShow’s Cannabis Investing Virtual Event on March 29th. For those not immersed yet...
Tweed Farms Achieves Major Milestone – 375 000 sq. ft. Now Approved for Dried Marijuana Production and Processing NIAGARA-ON-THE-LAKE, ON, March 31st, 2016 /CNW/ – Tweed Farms Inc. (“Tweed...
Terra Tech (OTC: TRTC), one of the more actively traded public cannabis companies, filed its 10-K with the SEC and reported a year-end review and outlook after the close....
Following through with a promise delivered on StockTwits last week, “The Vega Group” has published a negative report on GW Pharma (NASDAQ: GWPH) (LON: GWP). The stock had reacted...
Green Flower Media has been posting product review videos since the beginning of the year, and this week Mandee Lee reviewed the MyDx Analyzer on Try This. MyDx, Inc....
Motley Fool Contributor Todd Campbell, who operates E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors, has been cautious on the prospects for GW Pharma (NASDAQ:...
Investing in cannabis stocks remains perilous, as I will discuss in a presentation at MoneyShow’s Cannabis Investing Virtual Event on March 29th. With that said, there are a few...
Canopy Growth (TSXV: CGC) announced that it sold 4.35mm shares at a $2.30 offering price to a group of underwriters led by Dundee Securities. The “bought deal” means that CGC...
David Brown of Lift interviewed Aphria (TSXV: APH) CEO Vic Neufeld. Aphria is a licensed medical cannabis producer based in Leamington, Ontario. Company completed major expansion in October and received authorization...
Supreme Pharma (CSE:SL) (OTCMKTS:SPRWF) received its license from Health Canada to begin cultivating cannabis on March 11th. Based in Kincardine, Ontario, the company owns a large hybrid greenhouse facility,...
Meet Tweed Main Street: Bringing the Conversation to Main Street BARRIE, ON , March 17, 2016 /CNW/ – Tweed Inc. (“Tweed” or “the Company”) is pleased to unveil a...
Bruce Barcott reviewed portions of the impressive intellectual property portfolio of GW Pharma (NASDAQ: GWPH), which the company summarized in its annual filing: Our intellectual property portfolio at September 30,...
GW Pharma is trading near $74 following the issuance of a press release detailing the first of four late-stage clinical trials for its epilepsy drug, Epidiolex. The stock has...
Supreme Obtains MMPR License to Cultivate Medical Marijuana TORONTO, ONTARIO–(Marketwired – March 11, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its...
OrganiGram: Strong Q2 Sales and Inventory Highlights MONCTON, NEW BRUNSWICK–(Marketwired – March 11, 2016) – OrganiGram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) is pleased to announce its revenue results for...
Aphria to Report Positive Earnings for the Quarter 32% Revenue Growth Generating Significant EBITDA; Focus on Growing Practices Leads to 11% Decrease in Costs per Gram LEAMINGTON, ONTARIO–(Marketwired –...
Energy consumption is one of the big challenges for the cannabis industry, with indoor cultivation requiring large amounts of power to provide adequate lighting. Traditional lighting creates significant heat,...
Smaller licensed producers in Canada have tried to partner with publicly-traded companies in order to raise capital to compete with more established and better capitalized companies like Aphria, Canopy...
GW Pharma (NASDAQ: GWPH) (LON: GWP) will soon announce the results from the first of four Phase 3 clinical trials for Epidiolex, its antiepileptic drug targeting seizure reduction for patients with...
David Brown of Lift Cannabis interviewed Bruce Linton, CEO of Canopy Growth. The 25-minute interview covered a variety of topics, including development of the Tweed brand, the recent deal...
Canadian cannabis producer Canopy Growth, which owns Tweed, issued a press release this evening criticizing cannabis industry consultant Quantum 9: Who is Quantum 9? SMITHS FALLS, ON, March 2, 2016...
Cannabis companies have been increasingly under attack by Instagram and Facebook. Clay Dillow describes the recent Facebook fiasco for Dixie Brands, which lost 11K followers in an arbitrary instant....
